Background
==========

The cellular redox environment is determined by numerous electron couples, including glutathione/glutathione disulfide (GSH/GSSG), reduced thioredoxin/oxidized thioredoxin, NAD(P)H/NAD(P)^+^, and cysteine/cystine, that transfer electrons during changes in intracellular oxidation state. These redox couples are in turn maintained out of equilibrium by a network of biochemical reactions, connected through a common set of substrates, products and co-factors. The overall behavior of this system is regarded as the antioxidant capacity of the cell and it determines the rate of reactive oxygen species (ROS) clearance from the cellular environment. In prior work, we have quantitatively described through computational modeling the collective properties of the redox enzymatic network as it pertains to exogenous hydrogen peroxide clearance from the cytosol and protein thiol oxidation/reduction \[[@B1]\]. This computational analysis demonstrated the relative contributions of peroxiredoxins, glutathione peroxidase, catalase, and protein thiol/disulfide oxidation to the removal of hydrogen peroxide from the intracellular environment. This model was specific to the Jurkat T-lymphocyte cell line, yet through the adjustment of initial enzyme, glutathione, and NAD(P)H concentrations this model could in principle simulate the oxidative protection mechanisms of other cell types.

Cellular variability in redox potentials is well-documented; for example, resting glutathione potential can range from -200 mV to -260 mV depending on cell type and culture conditions \[[@B2]\]. Furthermore, sensitivity of the cellular redox potential to cell cycle \[[@B3]-[@B5]\], viral load \[[@B6]-[@B10]\], and remodeling during inflammation \[[@B11],[@B12]\] indicate that the set points of redox couples are readily altered by the \"malleability\" of redox enzyme gene expression. Numerous studies have examined the cDNA changes that occur across the genome in response to alterations in the oxidative environment (e.g. HIV infection, hypoxia, age); however these studies primarily report the significant up- or down-regulated gene hits from the conditions assayed without consideration of the subtle changes that could occur across the redox network.

Given that the expression levels of redox enzymes are readily altered, we asked whether targeted perturbation of specific redox couples would result in global remodeling of the redox enzyme network. RNA interference has become a common tool for biologists to quickly reduce protein levels in order to explore gene function with greater specificity than small molecule inhibitors can provide. Non-overlapping sequences of short hairpin RNA (shRNA) which have variable efficiency of interference can be exploited to generate \"epi-allelic\" cell lines with a range of protein silencing \[[@B13],[@B14]\]. As RNAi is utilized with greater frequency to investigate the role of oxidative protein thiol modifications in cellular function \[[@B15]-[@B22]\], it is important to consider the specificity of RNAi perturbations with respect to intracellular oxidant sources and sinks. The introduction of viral particles induces oxidative stress and can alter cellular antioxidant levels; this alteration of cellular protein levels \[[@B23],[@B24]\] may have unexpected redox-related consequences beyond potential off-target silencing, consequences that may substantially alter the redox capacity of the knockdown cells.

In order to discern changes in the redox environment that are primarily due to the on-target effects of viral incorporation as opposed to the off-target remodeling effects of redox couple perturbations, we performed a systematic analysis of the changes in expression of 28 redox-related genes due to stable RNAi knockdown of glutaredoxin 1 (Grx1), thioredoxin 1 (Trx1), or glucose-6-phosphate dehydrogenase (G6PD). We used computational programming to compare the redox ramifications of non-specific mRNA alterations to the redox ramifications of the idealized targeted knockdown scenarios. The dynamic analysis of intracellular hydrogen peroxide clearance indicates that surprisingly, while perturbing Trx1, Grx1, and G6PD have large consequences on antioxidant capacity, additional non-specific effects likely only modify the redox capacity of Grx1 shRNA transduced cells.

Results
=======

Knockdown creation and validation
---------------------------------

Lentiviral particles containing unique, non-overlapping mRNA sequences for each gene were used to generate shRNA-silenced Jurkat cell lines targeting Grx1, Trx1, and G6PD. Stable cell lines were created for each shRNA by puromycin selection. The most efficient shRNA for each gene of interest showed greater than 50% perturbation of mRNA levels as measured by qRT PCR (Figure [1A](#F1){ref-type="fig"}) and protein levels were further confirmed by western blot (Figure [1B](#F1){ref-type="fig"}). The fold changes in Grx1, Trx1, and G6PD levels were normalized relative to a housekeeping gene, β-actin, and compared to mRNA levels in the empty lentivirus (pLKO.1-puro) cells. The stable knockdown cell lines showed phenotypic differences in their growth rates (Figure [1C](#F1){ref-type="fig"}), with the Trx1 shRNA cells doubling at a slower pace than the other lines.

![**Characterization of shRNA cell lines**. (A) β-Actin normalized mRNA levels of target silencing in selected cell lines with respect to pLKO. (B) Expression levels of target protein after stable shRNA silencing of Grx1, Trx1, and G6PD in Jurkat cells compared to pLKO empty vector control. Selected shRNA sequence is denoted with asterisk. (C) Growth curves of selected stable knockdown cell lines show changes in cell proliferation rates between shRNA and control cells. Error bars represent ± standard error (n = 3).](1752-0509-5-164-1){#F1}

Variability of non-target redox enzymes
---------------------------------------

We designed a PCR array consisting of 28 gene targets (Table [1](#T1){ref-type="table"}) to examine the systematic variability of other non-targeted redox enzymes in the presence of shRNA lentiparticles. The genes selected for analysis were chosen to provide further insight into effects of lentiviral introduction on proteins that coordinate H~2~O~2~production, transport, and clearance from the intracellular environment. We first compared wild-type Jurkat cells to cells that had been stably transduced with empty lentivirus (pLKO.1-puro) and observed significant changes in cellular mRNA levels (Figure [2A](#F2){ref-type="fig"}, Additional file [1](#S1){ref-type="supplementary-material"}). The largest statistically significant fold-changes were observed in Duox1, Prx1, Grx2, and SOD1 mRNA levels (p \< 0.05). We attribute these large changes (\> ± 50%) in the redox regulatory network to a response to the cellular stress caused by viral integration into the genome. Minor but statistically significant changes of ± 20-50% were observed in mRNA of Prx4, Rac2, Ref1, IDH2, and CAT. All further references to the knockdown cell lines will be with respect to the pLKO control cells unless explicitly stated.

###### 

PCR array target list

  Gene Symbol   Alias                                        Accession \#   Official Full Name
  ------------- -------------------------------------------- -------------- -----------------------------------------------------------------------------------------
  CAT           MGC138422/MGC138424                          NM_001752      Catalase
                                                                            
  GPX1          GSHPX1/MGC14399/MGC88245                     NM_000581      Glutathione peroxidase 1
                                                                            
  GSR           MGC78522                                     NM_000637      Glutathione reductase
                                                                            
  PRDX1         MSP23/NKEFA/PAG/PAGA/PAGB/PRX1/PRXI/TDPX2    NM_002574      Peroxiredoxin 1
                                                                            
  PRDX2         MGC4104/NKEFB/PRP/PRX2/PRXII/TDPX1/TSA       NM_005809      Peroxiredoxin 2
                                                                            
  PRDX4         AOE37-2/PRX-4                                NM_006406      Peroxiredoxin 4
                                                                            
  APEX1         APE/APE1/APEN/APEX/APX/HAP1/REF1             NM_080649      APEX nuclease (multifunctional DNA repair enzyme) 1
                                                                            
  SRXN1         C20orf139/Npn3/SRX1/YKL086W/dJ850E9.2        NM_080725      Sulfiredoxin 1 homolog (S. cerevisiae)
                                                                            
  TXNRD1        GRIM-12/MGC9145/TR/TR1/TRXR1/TXNR            NM_003330      Thioredoxin reductase 1
                                                                            
  GLRX          GRX/GRX1/MGC117407                           NM_002064      Glutaredoxin (thioltransferase)
                                                                            
  GLRX2         GRX2/bA101E13.1                              NM_197962      Glutaredoxin 2
                                                                            
  TXN           DKFZp686B1993/MGC61975/TRX/TRX1              NM_003329      Thioredoxin
                                                                            
  TXN2          MT-TRX/MTRX/TRX2                             NM_012473      Thioredoxin 2
                                                                            
  G6PD          G6PD1                                        NM_000402      Glucose-6-phosphate dehydrogenase
                                                                            
  IDH1          IDCD/IDH/IDP/IDPC/PICD                       NM_005896      Isocitrate dehydrogenase 1 (NADP+), soluble
                                                                            
  IDH2          ICD-M/IDH/IDHM/IDP/IDPM/mNADP-IDH            NM_002168      Isocitrate dehydrogenase 2 (NADP+), mitochondrial
                                                                            
  AQP8          \-                                           NM_001169      Aquaporin 8
                                                                            
  DUOX1         LNOX1/MGC138840/MGC138841/NOXEF1/THOX1       NM_175940      Dual oxidase 1
                                                                            
  DUOX2         LNOX2/NOXEF2/P138TOX/THOX2                   NM_014080      Dual oxidase 2
                                                                            
  NOX1          GP91-2/MOX1/NOH-1/NOH1                       NM_007052      NADPH oxidase 1
                                                                            
  CYBB          CGD/GP91-1/GP91PHOX/GP91PHOX/NOX2/p91-PHOX   NM_000397      Cytochrome b-245, beta polypeptide
                                                                            
  NOX3          GP91-3                                       NM_015718      NADPH oxidase 3
                                                                            
  NOX4          KOX/KOX-1/RENOX                              NM_016931      NADPH oxidase 4
                                                                            
  NOX5          MGC149776/MGC149777/NOX5A/NOX5B              NM_024505      NADPH oxidase, EF-hand calcium binding domain 5
                                                                            
  RAC1          MGC111543/MIG5/TC-25/p21-Rac1                NM_006908      Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
                                                                            
  RAC2          EN-7/Gx/HSPC022                              NM_002872      Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
                                                                            
  SOD1          ALS/ALS1/IPOA/SOD/homodimer                  NM_000454      Superoxide dismutase 1, soluble
                                                                            
  SOD2          IPO-B/MNSOD/Mn-SOD                           NM_000636      Superoxide dismutase 2, mitochondrial
                                                                            
  ACTB          PS1TP5BP1                                    NM_001101      Actin, beta

The official full names, gene symbols, aliases, and accession numbers for the mRNA targets included in the PCR array.

![**Variability of non-target redox enzymes**. (A) Changes in off-target expression levels for wild-type Jurkat cells relative to pLKO empty vector control cells. Genes with significantly altered mRNA levels are colored green. (B) Changes in off-target expression levels for Grx1 shRNA (blue, circles), Trx1 shRNA (red, diamonds) and G6PD shRNA (orange, triangles), relative to pLKO control. (C) Venn diagram of significant gene changes. Statistical significance for all plots based upon p \< 0.05.](1752-0509-5-164-2){#F2}

The three silenced cell lines showed common non-specific effects as well as more target-specific variation as measured by qRT PCR. Surprisingly, silencing Trx1, Grx1, and G6PD each led to statistically significant decreases in Prx2 mRNA levels (11%, 35%, 13% expression, respectively). The Trx1 and Grx1 silenced cells also showed common reduction in sulfiredoxin 1 (Srx1) mRNA levels, while the Grx1- and G6PD-silenced cells both experienced reduced levels of Duox1 mRNA. The Grx1-silenced cells showed the most widespread off-target changes with respect to the control cells, with mRNA levels of 8 additional proteins affected: Prx4, IDH2, Ref1, Rac2, CAT, SOD2, G6PD, Trx2 (Figure [2B,C](#F2){ref-type="fig"}, Additional File [1](#S1){ref-type="supplementary-material"}).

In order to better determine what portion of the observed changes in mRNA levels was due to off-target effects of the shRNA and what portion could be attributed to lentiviral infection, we also compared the pLKO and shRNA cells to wild-type Jurkat cells (Additional File [1](#S1){ref-type="supplementary-material"}). With the exception of Prx2 for Trx1 and G6PD shRNA cells and Duox1 for G6PD shRNA cells, none of the significant changes in mRNA levels in our shRNA cells as compared to pLKO were accompanied by a similar change in mRNA levels in shRNA and pLKO cells when compared to wild-type cells.

In order to determine whether the measured changes in mRNA levels detected in our array reflected true changes in protein expression, each cell line was further assayed by western blot for Duox1 and Prx2 protein levels. These proteins could be further investigated because decreased levels of silencing were diverse enough in all three shRNA targets to create a broad range of values. As shown in Figure [3](#F3){ref-type="fig"}, the mRNA levels strongly correlated to protein levels for Duox1 (R^2^= 0.79), while the relation was stronger for Prx2 (R^2^= 0.91). Because the wild-type, uninfected cells represented an additional independent point to relate mRNA to protein, this measurement was included in the regression.

![**Correlation between protein and mRNA levels**. Representative blots showing variation in (A) Prx2 and (B) Duox1 protein levels due to off-target effects of lentiviral shRNA. Correlation between protein levels derived from these blots and mRNA level for (C) Prx2 and (D) Duox1 in shRNA cell lines and wild type Jurkat cells.](1752-0509-5-164-3){#F3}

Evaluation of co-variance among redox enzymes
---------------------------------------------

To evaluate patterns of co-variance among the mRNA levels, we modeled the array data by principal component analysis. This statistical modeling method, which collapses multivariate data into reduced dimensions, is useful for extracting patterns of co-variance across multiple observations. We created a data matrix consisting of five independent cell line observations: wild-type Jurkat cells, pLKO vector control, Grx1 shRNA, Trx1 shRNA and G6PD shRNA. Two principal components, or latent variables, were sufficient to explain 77.5% of the data variance, with PC1 capturing 44.4% and PC2 capturing 34.1%. The loadings plot as shown in Figure [4A](#F4){ref-type="fig"} illustrates relationships between genes. For example, the Trx2 and Ref1 mRNA levels are most tightly related among all variables as visualized by Euclidean distance. Some protein isoforms, such as the isocitrate dehydrogenases (IDH1, IDH2) map similarly in their contribution to the model. Likewise, the clustering of peroxiredoxin isoforms in the second principal component indicates that these proteins similarly contribute to the overall variance of the dataset, and likely reflect coordinated up- and down-regulation across the cell lines. Other isoform pairs (Trx1/Trx2 and SOD1/SOD2) show little co-variance and instead suggest insularity between mitochondrial and cytosol-specific proteins. Principal component analysis also highlights anticorrelative relationships by locations in opposing quadrants. In contrast to the IDH and Prx proteins, other isoforms have anticorrelative relationships, suggesting a compensatory effect in which cells up-regulate one gene to protect against the down-regulation of another. Protein pairs that fall within this category include Duox1/Duox2 and Nox1/Nox5.

![**Prediction of co-variance**. (A) Loadings plot of principal component analysis indicates strong co-variance between Grx1 and Prx2. (B) Off-target \"modulation\" of Prx2 by variable silencing of Grx1 in epi-allelic cell lines shows co-variance of Grx1 and Prx2 levels in three of four cell lines.](1752-0509-5-164-4){#F4}

Having established that our library of cell lines exhibited variation in both Prx2 mRNA and protein levels in response to the silencing of a variety of components within the redox regulatory network, we next asked if it was possible to modulate non-specific protein levels by shRNA-induced gradations in one of the redox couples. From the principal component analysis (Figure [4A](#F4){ref-type="fig"}), we predicted that Grx1 and Prx2 would strongly co-vary in levels. Three additional Grx1 shRNA stable cell lines ranging in efficiency from 20 to 65% knockdown levels were probed for Grx1 and Prx1, as was the wild-type cell line. We found that the Prx2 protein levels were co-expressed with Grx1 in three of our four cell lines (Figure [4B](#F4){ref-type="fig"}).

Cellular responses to oxidative stress
--------------------------------------

Because our results suggested that the shRNA cells possess a reduced capacity to handle oxidative insult, we tested the functional consequences of a perturbed redox couple in the presence of a bolus addition of 100 μM hydrogen peroxide. Previously, a computational model of cellular hydrogen peroxide clearance was developed and optimized for wild-type Jurkat cells \[[@B1]\]. Built primarily using mass action kinetics, this model is the most comprehensive to date for examining the relative contributions of the peroxiredoxin system, protein S-thiolation, catalase, and glutathione/glutathione peroxidase mechanisms for removing hydrogen peroxide from the intracellular cytosolic environment. The model is accurate for up to one hour of dynamic simulation post-addition of an exogenous bolus of hydrogen peroxide ranging from 0-100 μM and is capable of explaining the independence in timescales of the thioredoxin and glutathione redox couples. To make the model compatible with the enzymatic changes associated with lentiviral entry, parameters and initial conditions associated with the genes that had statistically significant differences by mRNA changes (p \< 0.05) between the pLKO cell lines and each of the other cell lines (Figure [2](#F2){ref-type="fig"}) were altered (Table [2](#T2){ref-type="table"}) to generate cell line-specific models. These models did not take into account possible changes in glutathione and NADPH content, nor potential post-translational alterations to proteins that could result from an altered basal redox status. Furthermore, as the model assumes a well-mixed compartment, it is incapable of describing the enzymatic production of H~2~O~2~that would occur due to NADPH oxidases.

###### 

Cell-line specific parameter sets for computational modeling

  Initial condition/rate constant   Jurkat    pLKO       Grx1 shRNA    Trx1 shRNA    G6PD shRNA
  --------------------------------- --------- ---------- ------------- ------------- -------------
  Grx1-SH (μM)                      1.2       1.2        **0.62**      1.2           1.2
                                                                                     
  Trx1~ox~+ Trx1~red~(μM)           0.505     0.505      0.505         **0.144**     0.505
                                                                                     
  G6PD (M⋅s^-1^)                    3.75e-4   3.75e-4    **2.55e-4**   3.75e-4       **1.24e-4**
                                                                                     
  Prx2-SH~2~(μM)                    19.2      19.2       **12.5**      **17.1**      **16.7**
                                                                                     
  Srx1 (s^-1^)                      3e-3      3e-3       **1.74e-3**   **1.95e-3**   3e-3
                                                                                     
  CAT (μM)                          0.9       **1.17**   **0.8**       0.9           0.9

Numbers in bold represent altered parameters from the wild-type Jurkat cell line.

We compared the simulations of these models in response to a 100 μM bolus treatment of hydrogen peroxide to the idealized case of perfect, specific targeting. These simulations were conducted to determine the effect of off-target alterations on the intracellular redox buffering capacity of the knockdown cell lines. Results of this analysis reveal that the off-target alterations caused by the introduction of pLKO shRNA, Trx1 shRNA, and G6PD shRNA lentiviral particles do not result in significant changes to the intracellular redox buffering capacity of the respective knockdown cell lines (Figure [5](#F5){ref-type="fig"}). However, the off-target alterations that result from Grx1 shRNA targeting result in significant alterations to the intracellular redox buffering capacity of the Grx1 knockdown cells (Figure [5](#F5){ref-type="fig"}). Upon further analysis of the off-target proteins that are affected by each of the shRNA constructs, it was discovered that the Grx1 shRNA lentiviral particle was the only lentiviral particle whose cellular introduction resulted in the off-target alteration of the G6PD enzyme. Based on this finding, we hypothesized that the off-target alteration of the G6PD enzyme was the primary additional modulation that was responsible for the significant differences seen between the ideal Grx1 knockdown behavior and the Grx1 knockdown behavior in the presence of off-target effects. To test this possibility, we simulated the hypothetical redox behavior of the Grx1 knockdown cell line without any off-target effects (i.e. idealized case) and with all off-target effects except for those involving the G6PD enzyme (Figure [6](#F6){ref-type="fig"}). These simulations suggest that if G6PD is not an off-target of Grx1 shRNA, then the Grx1 knockdown cells with off-target alterations should have the same redox buffering capacity in the presence of exogenous peroxide addition as the ideal Grx1 knockdown cells with no off-target alterations.

![**Simulated consequences of the redox effects of off-target variations in shRNA perturbation**. Model predicted dynamics of intracellular H~2~O~2~accumulation (first column), glutathione redox potential (second column), thioredoxin redox potential (third column), and Pr-SSG accumulation (fourth column) after a 100 μM extracellular H~2~O~2~treatment. Solid lines represent the model-predicted behavior for the ideal KD cell lines with no off-target effects (w.t., Grx1, Trx1, G6PD), and dashed lines represent the model-predicted behavior for the experimentally characterized shRNA cell lines with qRT PCR-determined off-target effects (pLKO, Grx1\*, Trx1\*, G6PD\*).](1752-0509-5-164-5){#F5}

![**G6PD off-target effect significantly alters intracellular redox capacity in knockdown cell lines**. Model predicted dynamics of intracellular H~2~O~2~accumulation (first column), glutathione redox potential (second column), thioredoxin redox potential (third column), and Pr-SSG accumulation (fourth column) in the Grx1 knockdown cell line after a 100 μM extracellular H~2~O~2~treatment. Solid black lines represent the model-predicted behavior for the ideal knockdown cell lines with no off-target effects (Grx1), red dashed lines represent the model-predicted behavior for the experimentally characterized shRNA cell lines with all qRT PCR-determined off-target effects except those affecting the G6PD enzyme, and blue dotted lines represent the model-predicted behavior for Grx1 silencing only in the presence of G6PD off-target effects.](1752-0509-5-164-6){#F6}

To establish the possible synergy of altered Grx1 and altered G6PD as drivers of redox state, we simulated conditions where only these two proteins are altered in the redox network versus all off-target effects except G6PD (Figure [6](#F6){ref-type="fig"}). Inclusion of the other Grx1 shRNA off-target proteins closely mimics the \"idealized\" case of just Grx1 silencing. In contrast, simulations of the Grx1 shRNA silencing solely in the presence of off-targeted reduction of G6PD dramatically influences the system behavior. This further indicates that the loss of robustness in redox capacity is due to a combined effect of Grx1 and G6PD.

Discussion
==========

Perturbations of cellular redox couples are instructive in applications that investigate the mechanisms of thiol-based signaling, protection from inflammatory reactive oxygen species and the metabolism of cysteines. Use of small molecule inhibitors such as carmustine (inhibitor of glutathione reductase) or dehydroepiandrosterone (inhibitor of G6PD) provide rapid alterations in the behavior of the redox enzymatic network, but this is potentially at the expense of specificity. Alternatively, small interfering RNA (siRNA) can transiently reduce protein levels with a high degree of specificity, but cellular characterization of the induced changes is often limited by the viability and transduction efficiency of the cells under investigation. Lentiviral infection of shRNA is purported to address both specificity and cell number limitations through the selection for stable incorporation of the interfering RNA within the genome. An additional benefit of stable silencing is the ability to assess long-term changes in the expression levels of other genes in response to the target. These changes take place on time-scales that vary among individual proteins; for example, in a genome-wide study of mouse embryonic stem cells, mRNA of NAD(P)H oxidase isoforms decay with half-lives on the order of 4-5 hours, while peroxiredoxins 1 & 2 and isocitrate dehydrogenase 1 & 2 had half-lives of 20-24 hours \[[@B25]\]. Consequently, when accounting for changes in mRNA and protein decay rates and sequential feedback, cellular remodeling in response to a silenced redox protein may not be fully implemented across all proteins to a new homeostatic state for several days. All of the shRNA cell lines used for this study had undergone at least three passages from the lentiviral infection and puromycin selection before characterization.

Because of the advantages to using shRNA, this method of examining redox regulation of cellular processes has been increasingly used to study effects of NAD(P)H supply, glutaredoxin, thioredoxin, and associated reductases \[[@B16]-[@B22]\]. Many of these studies rely on perturbation of the target protein in order to observe a phenotypic change, such as sensitivity to diamide-induced oxidative stress \[[@B19]\] or increased cellular senescence \[[@B22]\], and rely on the assumption that the rest of the antioxidant enzyme system remains intact. Our results, however, question this assumption by the changes observed in both the empty lentiviral construct and off-target changes due to specific protein silencing. We measured dramatic changes in redox protein mRNA levels due to the presence of the empty lentiviral vector, compared to uninfected cells. This is consistent with a vector-independent interferon response that is initiated by shRNA \[[@B26]\] or altered regulation of autocrine cytokines \[[@B27]\]. Furthermore, interferon γ stimulated response elements (ISRE) have been identified in the promoter regions of Nox1 and Nox2 \[[@B28],[@B29]\] and therefore may potentially also control expression levels of other proteins involved in regulation of ROS, such as Duox1 and Rac1. Grx1 has been reported to be an essential regulator of interferon response factor-3 in Sendai virus infected cells \[[@B30]\]; if this role is conserved in all lentiviral infection, this mechanism may partially account for the sensitivity of the Jurkat cells to Grx1-specific RNA interference. Phosphorylation of the α subunit of eukaryotic initiation factor 2 (eIF2) through protein kinase R (PKR) is induced by IFN-γ and TNF-α \[[@B31],[@B32]\] as well as a variety of stress conditions, including viral infection, and has been shown to down-regulate protein synthesis \[[@B33],[@B34]\]. Therefore, lentiviral infection could potentially have post-translational effects on eIF2-α, thereby altering the regulation of protein synthesis. It should also be noted that treatment with aminoglycoside antibiotics has been shown to have effects on the expression levels of Grx1, and oxidative stress induced by antibiotics should be included as a potential cause for the changes we observed \[[@B35]\]. We have taken this into account in our experiments by using a control cell line (pLKO vector cells) that was cultured in the same puromycin-containing media as our shRNA cells. We compared our shRNA cells to this cell line and also compared mRNA levels in our shRNA and pLKO cell lines to that of wild-type cells (Figure [2](#F2){ref-type="fig"}, Additional file [1](#S1){ref-type="supplementary-material"}); however, a direct comparison of the effects of puromycin was not feasible, as puromycin was toxic to our wild-type cells.

In past cDNA microarray studies of responses associated with oxidative stress, transcriptional changes are reported as up- or down-regulated expression levels rather than the coordinated regulation of the redox-related enzymes \[[@B36]-[@B39]\]. Prior microarray studies on virally-infected T cells have not reported significant changes across the antioxidant enzyme network as observed in the present analysis, instead yielding one or two redox-related genes in the genomic arrays \[[@B40],[@B41]\]. In contrast, other studies have demonstrated careful characterization of antioxidant enzyme changes, but only on a select few proteins (e.g. \[[@B42]\]). Systematic histological characterization of redox protein distribution provides complementary information, but does not allow for direct multivariate expression relationships on a large scale \[[@B43]\]. The intent of this study was to provide a more targeted approach with proteins that coordinate H~2~O~2~production and clearance from the intracellular environment while still monitoring enough genes to observe systemic effects. Microarray and qRT PCR results may not always directly correspond to protein levels; however for a subset of proteins characterized in the present data (Grx1, Trx1, G6PD, Prx2, and Duox1) a linear relationship between mRNA and protein levels was observed.

Peroxiredoxins have emerged as important regulators of cellular redox status \[[@B1],[@B44]\]. Among the coupled reactions of peroxiredoxin, thioredoxin, and sulfiredoxin, our network approach yielded novel insight into the regulation of this enzyme family (Figure [4A](#F4){ref-type="fig"}). A strong co-expression pattern emerged between the three peroxiredoxins measured (Prx1, 2, 4). Thioredoxin reductase also tightly co-varied with the peroxiredoxins while Trx1 showed less relation. A direct correlation between Srx1 and the rest of the peroxiredoxin branch was not established across the cell lines assayed, but the Trx1 knockdown cells showed a significant decrease in Srx1 (35%, p \< 0.05). The off-target Srx1 compensation caused by attenuation of thioredoxin 1 expression may be more tightly regulated than our analysis suggests and could be explored further by epi-allelic strains of Trx1 shRNA targets. The distance between Prx2 and Grx1 in the principal component analysis demonstrated a stronger expression regulation between these two proteins than with Srx1 or Trx1. Because glutaredoxin 1 is not a substrate for the peroxiredoxins \[[@B45]\], this trend was unexpected but it was supported by analysis with additional cell lines. It has been postulated by Winterbourn and Hampton that additional functionality of peroxiredoxins through facilitated, indirect oxidation of other proteins could provide an alternate method of oxidative signal transmission \[[@B46]\]; if protein sulfenic acid is generated in this manner and subsequently protected by S-glutathionylation, than coordination between peroxiredoxins and Grx1 expression would be appropriate.

Disequilibrium of redox couples between the cytoplasm, ER, mitochondria, and nuclei has been elucidated through investigations of the differential subcellular sensitivities to oxidative stress \[[@B2],[@B47]-[@B54]\]. The nature of the oxidative stress preferentially impacts different locations \[[@B55]\]; for example, EGF signaling induces Trx1 oxidation \[[@B51]\], while Trx2 is preferentially oxidized with TNF-α treatment \[[@B56]\]. The co-varying relationships and expression patterns illustrated in Figure [4A](#F4){ref-type="fig"} indicate that this insularity extends to a lack of up-regulated compensation of alternate isoforms when a cytosolic component (Trx1, Grx1) is altered, as we observed no statistical differences in the corresponding mitochondrial Trx2 and Grx2. In contrast, the computational modeling results suggest changes in the cytosolic NAD(P)H supply by G6PD silencing may result in enhanced mitochondrial NAD(P)H production by a dehydrogenase, IDH2. A significant decrease (35%, p \< 0.05) in Trx2 upon Grx1 silencing was detected, however, but no known mechanism for communication between these compartmentalized redox proteins is known.

Changes due to the presence of the lentivirus could be accounted for with proper control experiments if not for the added non-specific off-target effects resulting from manipulating the various redox couples through RNA interference. The shRNA sequences used in the present study were for disparate protein targets with unique sequences, thus the changes observed are attributed to compensation by the cell for decreased reducing capabilities rather than direct silencing by RNA interference. Computational analysis allowed for the direct comparison of the idealized shRNA specificity to the more likely behavior if changes in mRNA levels reflect changes in protein translation. Although all the cell lines with lentivirus except the Grx1 shRNA knockdown cell line showed insignificant differences in antioxidant capacity due to off-target effects, it should be noted that not all the off-target effects detected by qRT PCR were capable of being simulated using the current cytosolic model. For example, downregulation of oxidative enzymes such as the Nox/Duox family, which would likely impact signaling-induced antioxidative responses, is not reflected in the models. This feature of ROS production is missing as the computational description only accounts for the dissipation of H~2~O~2~by permeation through the cell membrane and clearance by glutathione, peroxisomes, and cytosolic enzymatic reactions. Our data shows that Duox1 was significantly downregulated in both the Grx1 and G6PD shRNA cell lines. It is possible that a more comprehensive model, one which is spatially descriptive and includes mitochondrial and membrane related antioxidant enzymes, could more readily show the resulting effect of off-target alterations on cellular antioxidant capacity. However, with the current modeling analysis, it is clear that off-target effects involving the G6PD enzyme system are more likely to result in significant changes in the overall redox capacity of the cell, compared to the idealized knockdown condition.

A caveat of our simulations is the numerous metabolic and post-translational modifications that are likely occurring in the cell lines. Although we maintained uniform redox state of NADPH/NADP^+^, Trx1-SH~2~/Trx1-SS, and GSH/GSSG for each cell-line specific model, each of these may be altered in response to the lentiviral constructs. For instance, G6PD knockdowns cells have been shown to exhibit an impaired ability to regenerate GSH \[[@B17]\]. Another caveat is that we have assumed that changes in mRNA levels will be reflected in protein levels. Although our detailed analysis of two proteins did show a linear correlation between mRNA and protein (Figure [3](#F3){ref-type="fig"}), this relation may not be upheld for all proteins due to translational regulation. Furthermore, proteins beyond the scope of our array involved in transport and metabolite synthesis may be altered to control the total available pools of NADPH and glutathione. Our analysis, therefore, is useful strictly as a means of examining one aspect of redox remodeling associated with viral infection and shRNA.

A surprising finding of our experimental and computational work is the dichotomy between the numerous changes that result at the mRNA level due to the introduction of lentiviral mRNA and the minor possible functional consequences in the overall ability of cells to handle acute, exogenous oxidative insult. Our shRNA perturbations of each redox couple indicated sensitivity to protein levels that were apparent only by inspection of multiple metrics of oxidative stress (Figure [5](#F5){ref-type="fig"}). With the exception of the Grx1/G6PD relationship, the off-target effects largely did not influence functionality of the redox enzymatic network as tested by our simulations. These results need to be investigated experimentally; for example, future studies of combined targeted silencing of both genes could characterize the necessary ratios of each protein required to maintain a robust redox system. Additional experiments are also necessary to establish whether the concomitant downregulation of ROS producing enzymes and enzymes involved in ROS scavenging is reflected in an increased resistance to cellular oxidation required for many signal transduction processes.

Conclusions
===========

In conclusion, this systemic study of gene co-regulation upholds findings of biochemical network analyses \[[@B1],[@B57],[@B58]\], namely that global cellular antioxidant capacity is a finely-tuned balance of multiple redox reactions tightly interconnected through common NAD(P)H supply, requiring systems-level characterization of reversible thiol oxidation. RNA interference provides a method to directly manipulate components of the pertinent oxidation and reduction enzymes where small molecule inhibitors are unavailable, but at a cost of unintentionally altering other aspects of the network. Attenuation of oxidases and associated regulatory components is one way that cells adjust to a perturbed antioxidant capacity. Computational approaches such as principal component analysis harness the unintended off-target effects in order to glean insight into compensatory measures that cells utilize as protection against oxidative damage; however our analysis points to challenges that can arise in implementing cell line-specific dynamic models if all non-specific effects are not built into the new parameter sets. While the application in the present study was RNAi-induced changes, this methodology of analysis would be useful in studying other forms of chronic reductive or oxidative stress.

Methods
=======

Cell culture
------------

Jurkat cells (ATCC, Manassas, VA) were cultured in RPMI-1640 medium (Sigma-Aldrich, St Louis, MO) supplemented with 10% FBS, 1% HEPES, 1% MEM non-essential amino acids, 1% sodium pyruvate, 100 U/ml penicillin, and 100 μg/ml streptomycin. Knockdown cells were cultured in the above medium with an addition of 4 μg/ml puromycin. Cells were cultured at a density of between 0.2 and 1.5 × 10^6^cells/ml in a humidified atmosphere of 5% CO~2~and 95% air at 37°C. For proliferation studies, cell density was calculated by hemocytometer every 24 hours.

RNA interference
----------------

Stable knockdowns were created from Jurkat cells by targeting the expression levels of Grx1, Trx1 or G6PD, using MISSION Lentiviral shRNA Transduction Particles (Sigma-Aldrich) according to manufacturer\'s protocol with puromycin selection (4 μg/ml). Jurkat cells with empty pLKO.1-puro lentiviral plasmid were used as control cells. MISSION TurboGFP™ Control Transduction Particles (Sigma-Aldrich) were used in a parallel experiment as a control for transduction efficiency.

qRT PCR
-------

RNA was isolated from cells using the RNeasy isolation kit (SABiosciences, Frederick, MD) with RNase-free DNase set (Qiagen, Valencia, CA) according to the manufacturer\'s protocol. 1 μg of RNA was used for reverse transcription. The reverse transcription reactions were performed using the SuperScript III First-Strand Synthesis System (Qiagen) for Trx1 shRNA validation and the RT2 first Strand Synthesis Kit (SABiosciences) for Grx1 shRNA validation and PCR array. Both kits were used according to manufacturer\'s protocol.

For shRNA validation, qRT PCR was run using primers for human Grx1, Trx1, and G6PD (SABiosciences). For detection of other mRNA levels, a custom RT2 Profiler PCR Array (SABiosciences) was used, according to manufacturer\'s protocol. A list of targets included in the array can be found in Table [1](#T1){ref-type="table"}. PCR conditions were as follows: 10 min at 95°C; 40 cycles of 1 minute at 60°C and 15 seconds at 95°C; melt curve with ramp from 60°C to 95°C. All PCR reactions were run using the Step One Plus system (Applied Biosystems, Carlsbad, CA). Results were normalized to the expression of β-actin. Relative expression levels were calculated using the ΔCT method (2^-ΔCT^). All arrays were performed with triplicate sets of RNA isolation for each cell line for statistical analysis.

Cell lysis for western blotting
-------------------------------

For western blotting, 8 × 10^6^cells were lysed in 200 μl lysis buffer buffer containing 2% NP-40, 50 mM β-glycerophosphate, 10 mM NaP, 30 mM NaF, 50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM benzamidine, 2 mM EGTA, 100 μM sodium orthovanadate, 1 mM DTT, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 μg/ml pepstatin, 1 μg/ml microcystin-LR, and 1 mM PMSF. Cells were lysed on ice for one hour, followed by centrifugation for 10 minutes at 14000 rpm. Protein concentration was determined with the Micro BCA™ Assay Kit (ThermoFisher Scientific, Waltham, MA). For ΔPr-SSG blots, cells were lysed in a non- reducing buffer containing 2% NP-40, 50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM benzamidine, 2 mM EGTA, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 μg/ml pepstatin, 20 mM ethylmaleimide, and 1 mM PMSF.

Western blotting
----------------

For western blots, 20 to 40 μg of total protein/sample was subjected to SDS-PAGE and transferred to PVDF membranes. For Pr-SSG blots, this was done under non-reducing conditions. The membrane was blocked with Near Infra-Red Blocking Buffer (Rockland Immunochemicals, Gilbertsville, PA) at room temperature for 1 hour. Primary antibodies were used at a dilution of 1:1000 in 10 ml blocking buffer and incubated over night at 4°C, followed by three washes in TBS-T. Secondary antibodies (IR dye 680CW donkey anti-mouse, IR dye 800CW anti-goat or IR dye 800CW donkey anti-rabbit, all from LI-COR Biosciences (Lincoln, NE), were all used at a dilution of 1:15000 in 10 ml blocking buffer and incubated for 1h at room temperature. This was followed by two washes in TBS-T and one wash in TBS. Imaging and image analysis were done using the Li-Cor Odyssey Infrared Imaging System with the Odyssey 2.1 software. β-actin was used as loading control. Primary antibody for Grx1 was purchased from R&D Systems (Minneapolis, MN), for full length Trx1 from BD Biosciences (Franklin Lakes, NJ), for Duox1 from Novus Biologicals (Littleton, CO), for Prx1 from Millipore, for Prx2 from Abcam (Cambridge, MA), for glutathione from Virogen (Watertown, MA), and for β-actin from Sigma-Aldrich.

Statistical analysis
--------------------

All values reported are the average of three independent biological replicates +/- standard error. Statistical significance is based upon the criteria of p \< 0.05 for a Student\'s t-test (two-tailed, equal variance). Principal component analysis was performed by first mean centering and unit variance scaling the 2^ΔCt^values (normalized to β-actin) to create a 5 × 28 data matrix. Simca-P software (Umetrics, Umeå, Sweden) provided stringency tests for determining the minimum number of latent variables (components) necessary to capture covariance in the data.

Modeling simulations
--------------------

A previously published model of the redox regulatory network was originally developed and optimized for wild-type Jurkat parameters \[[@B1]\]. This model was capable of simulating the clearance of 100 mM exogenous hydrogen peroxide from the cytosolic environment at a cell density of 10^6^cells/mL. A fundamental feature of the kinetic description is the use of changes in species from baseline instead of absolute concentrations due to the inherent disequilibrium in redox couples \[[@B2]\]. For the simulations presented here, all model parameters and files are identical to those in \[[@B1]\] except where noted below, and the kinetic equations can be found in Additional File [2](#S2){ref-type="supplementary-material"}. The model was adjusted to new baseline values for the pLKO, Grx1 shRNA, Trx1 shRNA, and G6PD shRNA by calculating the fold change for statistically significant differences (p \< 0.05) in RNA levels of the following genes as described in Table [2](#T2){ref-type="table"}: Prx2, G6PD, Grx1, Trx1, CAT, and Srx1. Changes to alternate isoforms of these genes (e.g Prx1, Prx4, Grx2, Trx2) were not factored into the model simulations in Figures [5](#F5){ref-type="fig"} &[6](#F6){ref-type="fig"}. The components that are represented in the model as species had their total concentrations adjusted accordingly. The components whose levels were implicitly reflected in a rate constant (G6PD, Srx1) had a fold-change alteration in parameter value. For the idealized cases, only the target of interest (Grx1, Trx1, and G6PD, respectively) was altered according to the altered mRNA value. Simulations of 60 minute responses were performed using Matlab 7.9.0 r2009b.
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###### Additional file 1

**Significant changes in mRNA expression levels in shRNA and pLKO cells lines**. Significant changes (p \< 0.05) in mRNA expression levels in shRNA cell lines and pLKO control cells compared to wild-type Jurkat cells, and in shRNA cells and wild-type cells compared to pLKO cells. Names in black represent targets that were expressed in all five of our cells lines, while names in red represent mRNA targets that were not expressed (Ct ≥ 35) in any of our cells lines.
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###### Additional file 2

**Description of computational model used for simulations in figures**[5](#F5){ref-type="fig"}**and**[6](#F6){ref-type="fig"}. Further details of model description and sources for parameter values can be found in Adimora NJ, Jones DP, Kemp ML. \"A model of redox kinetics implicates the thiol proteome in cellular hydrogen peroxide responses.\" Antioxid Redox Signal 2010, 13:731-743. Each cell line represented in the simulations was modified by adjusting the subset of parameters listed in Table [2](#T2){ref-type="table"} of the main text.
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